EP3624838
METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION
:
EP einkaleyfi: Þýðing ekki lögð inn:
15.5.2018:
25.1.2023:
18801838.6
:
14.5.2038
:
METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION
15.5.2018
25.1.2023
:
Oncoimmune, Inc.:
9430 Key West Avenue Suite 113, Rockville, Maryland 20850, US
:
Children's National Medical Center:
111 Michigan Avenue N.W., Washington, DC 20010, US
:
LIU, Yang:
Washington District of Columbia 20002, US
:
ZHENG, Pan:
Washington District of Columbia 20002, US
:
LI, Ning:
Vestal New York 13850-2873, US
:
DEVENPORT, Martin:
Gaithersburg Maryland 20878, US
:
201762506135 P:
15.5.2017:
US
:
US2018032699:
15.5.2018
:
A61K 38/17, A61K 48/00, A61P 25/28, C07K 14/705, A61K 47/68, A61P 25/16